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Summary  
The interleukin-1 (IL-1) cytokines stimulate the synthesis of degradative enzymes in joint tissues and may play a role 
in the pathological joint destruction i osteoarthritis (OA). In this study, we have used immunohistochemistry and 
Western blot analysis to identify IL-1 in human OA cartilage. IL-lu and IL-I~ were evident in chondrocytes atthe 
articular surface, as well as di tributed throughout the cartilage. In_many specimens, IL-I~ but not IL-I~ was detected 
as a diffuse staining of the extracellular matrix especially surrounding superficial zone chondrocytes. Although 
chondrocyte-associated IL-I~ and IL-I~ were detected in most specimens, cartilages exhibiting early osteoarthritic 
changes had the highest intensity of staining and the highest frequency of positive cells. Western blot analysis revealed 
intense immunoreactive bands corresponding to the 35 kDa precursor form of IL-I~ in all four chondrocyte lysates 
tested. The processed 18 kDa IL-I~ species was present in only one of four chondrocyte lysates, and there was no clear 
evidence of precursor form within these cells. The results of this study indicate increased IL-I~ in cartilage showing 
early degenerative changes, suggesting an utocrine/paracrine rol  for this cytokine in OA pathogenesis. 
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Introduct ion 
INTERLEUKIN (IL)-lu and IL-I~ are potent 
proinflammatory molecules [for review see 1, 2]. 
The two forms are distinct gene products that exert 
their effects by binding to shared, high-affinity 
receptors on a variety of target cells including 
articular chondrocytes [3, 4]. The activity of these 
short-range mediators i regulated at several levels 
including transcriptional nd post-transcriptional 
regulation of gene expression [1, 2], secretion by 
poorly-defined, non-conventional pathway(s) [5], 
activation of precursor IL-1 ~ by specific proteolysis 
[6-8], and inhibition by IL-1 receptor antagonist 
[9-11]. 
IL-ls have been implicated in the pathogenesis of 
degenerative joint diseases. These cytokines cause 
cartilage resorption both in vitro and in vivo 
[12-14] probably, at least in part, by increasing the 
synthesis of matrix metalloproteases by the 
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cartilage [15-20]. IL-1 cytokines have been found in 
synovial fluids of patients with rheumatoid and 
osteoarthritis (OA) [21-23]. It is generally accepted 
that IL-ls are important mediators in the cartilage 
destruction seen in inflammatory joint disease, but 
the role of these cytokines in the pathogenesis of
OA is less clear [24]. 
We were the first to report the presence of IL-I~ 
and ~ mRNA in chondrocytes isolated from 
apparently-normal human cartilage, and to show 
the production of IL-I~ by cartilage in explant 
culture [25]. We speculated on the possibility that 
chondrocyte-derived cytokines might act in an 
autocrine or paracrine fashion to promote carti- 
lage destruction in OA. Lending support to this 
hypothesis was the immunochemical demon- 
stration of IL-1 in the articular cartilage from dogs 
rendered osteoarthritic by severing the anterior 
cruciate ligament [26]. In that study, the articular 
cartilage in the operated joints showed features 
typical of moderate OA 12 weeks after surgery. 
IL-lc~ and IL-I~ were detected primarily in 
superficial regions of the OA cartilage, but also in 
the middle zone and along fissures. Cartilage of 
unoperated limbs was histologically normal and 
negative for IL-ls. IL-1, tumor necrosis factor-c~ 
(TNF-~) and IL-6 were reported to be present in 
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human OA cartilage and more abundant in the 
middle zone of degenerated cartilage [27]. 
In the study reported here, we used antibodies to 
IL-I~ and IL-I~ to show that these cytokines are 
associated with chondrocytes in human OA 
cartilage. While a synovial fluid origin for these 
cytokines is possible, the presence of precursor 
IL-I~ in OA chondrocyte lysates argues for 
synthesis of at least this form by these cells. 
Cartilages showing early osteoarthritic hanges 
exhibited more intense immunostaining and a 
higher frequency of positive cells than more 
severely-degenerated specimens or specimens from 
individuals without a history of joint disease. Our 
results indicate that the chondrocytes produce 
IL-I~ early in the development of OA, providing 
support for an autocrine/paracrine role for this 
cytokine in OA pathogenesis. 
Materials and Methods 
Samples of OA cartilage were obtained from 
patients undergoing knee or hip replacement 
arthroplasty. Articular cartilage was obtained 
from femoral heads of hip joints or from the 
femoral condyle and tibial plateau of knee joints. 
Gross examination of some of these specimens 
revealed considerable focal variability in the 
extent of osteoarthritic hange to the articular 
surfaces. In these cases, two or three specimens 
were obtained from fibrillated and non-fibrillated 
regions and individually processed. Articular 
cartilage specimens obtained from individuals 
without a history of joint disease (cartilage 
obtained from the femoral condyle at autopsy 
within 12 h of death or from patients undergoing 
amputations for tumors at remote sites) were 
similarly processed. Adjacent histological sections 
of each specimen were scored for OA severity and 
the presence of chondrocyte IL-1 immunoreactivity 
as described below. 
Cartilage cores (5 mm diameter) were excised 
using a cork borer. The cores were bisected 
longitudinally, fixed overnight at 4°C in 4% 
paraformaldehyde in phosphate-buffered saline 
(PBS), and frozen in liquid nitrogen before storage 
at -70°C. Cryostat sections (6 ~m) of cartilage were 
placed on slides and air-dried. Alternatively, 
paraformaldehyde-fixed specimens were dehy- 
drated and embedded in paraffin. Sections from 
each core were stained with safranin-O fast green 
hematoxylin. Safranin-O stained sections were 
examined for features such as staining intensity, 
cellularity, and integrity of the articular surface, 
and specimens were scored for OA severity using 
the histological histochemical grading system of 
Mankin et al. [28] except that the vascular 
penetration of the 'tidemark' was not evaluated. 
(The tidemark was not observed in most speci- 
mens.) 
Adjacent sections from the same cores were 
examined for IL-I~ and IL-I~ by immunochemical 
staining. Endogenous peroxidase activity was 
quenched with 0.3% H202 in methanol. The 
sections were incubated at 37°C with chondroiti- 
nase ABC (Sigma Chemical Co., St. Louis, MO, 
U.S.A.: 0.25U/ml in PBS) for 2h, and further 
incubated l h with 5% normal goat serum 
supplemented with 2 mg/ml heat aggregated goat 
IgG as necessary to reduce background staining. 
Sections were incubated overnight at 4°C with 
rabbit anti-human rlL-l~ (2 ~g/ml), rabbit anti 
human rIL-l~ (8 ~g/ml) immunoglobulin G (IgG, 
both from Genzyme, Cambridge, MA, U.S.A.), or 
with the same concentration ofnon-immune rabbit 
IgG (Pierce Chemical Co., Ro%kford, IL, U.S.A.). 
Additional controls for the specificity of staining 
included omission of the first antibody and 
preabsorbtion of immune serum with 50 ~g recom- 
binant IL-1. Slides were washed three times with 
PBS, and the bound rabbit IgG was detected using 
the Vectastain ABC kit (Vector Laboratories) with 
diaminobenzidine t trahydrochloride (DAB) as the 
chromagen. Slides were lightly counterstained 
with methyl green. 
Specimens were assigned numerical scores for 
IL-I~ and IL-I~ based on the percentage of cells 
positive for each: no immunoreactive c lls, 0; less 
than 26% as 1, 26-50% as 2, 51-75% as 3, and 
greater than 75% positive as 4. Duplicate slides 
from each specimen were evaluated by two 
independent observers, with additional sections 
being examined if necessary to resolve differences. 
Individual readings by the two observers were 
generally identical, as were the scores for 
duplicate slides. 
For cartilage from OA patients, the mean 
immunochemical score was determined for each 
histological grade, and the correlation of IL-I~ and 
IL-I~ staining with histological grade was determi- 
ned by linear regression analysis. Immunochemical 
scores for mild to moderate OA cartilage (histologi- 
cal grade I 6), severe OA cartilage (grade 7-10), 
and cartilage from patients without a history of 
joint disease were compared using Student's 
two-tailed t-test. 
For Western blot analysis of IL-1 in chondro- 
cytes, cells were isolated from the articular 
cartilage obtained from four OA specimens (grade 
4) by digestion with 0.08% clostridial collagenase. 
Cell extracts were prepared by resuspending the 
washed chondrocyte pellets in lysis buffer (0.02 M 
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tris HC1, I mM ethylene diamine tetraacetic acid, 
0.5% Triton X-100 pH 7.8). Cellular proteins (40 ~g) 
were adjusted to 1% sodium dodecyl sulfate, 10% 
glycerol and resolved by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis. Resolved pro- 
teins were electrophoretically transferred to 
Immobilon. Membranes were blocked by incu- 
bation for 1 h in 3% gelatin in TBS (0.02 M Tris 
[b) 
FIG. 1. Photomicrographs of sections from a representative specimen of OA cartilage (grade 4). Sections were stained 
with rabbit anti-human rIL-l~ at 2 ~g/ml IgG [(a) and (b)] or rIL-l~ at 8 pg/ml IGg [(c) and (d)] and counterstained with 
methyl green. The sections photographed at higher magnification [(b) and (d) x400 original magnification] show 
staining of chondrocytes for each of the cytokines. IL-I~ and IL-I~ immunoreactive chondrocytes were distributed 
throughout the superficial and deeper layers of the cartilage. Sections from the same specimen processed using normal 
rabbit IgG (8 ~tg/ml) in place of the primary antibody [(e) and xl00; (f), x400] show background staining. 
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FIG. 2. Immunochemical score for (a) IL-I~ and (b) IL-I~ 
plotted against he histological grade for OA severity of 
cartilage from OA patients. Data are mean immuno- 
chemical score__+ SEM for each histological grade. 
Number of specimens at each grade ranged from 2 9. 
Linear regression analysis yielded R2=0.825 for IL-lu 
and R2=0.577 for IL-I~. 
HC1, 0.15M NaC1 pH7.8). Membranes were 
incubated for 3 h with rabbit antisera to IL-I~ or 
IL-I~ (10 ~g/ml in TBS with 1% gelatin and 0.05% 
Tween 20), washed with TBS Tween, and incubated 
1 h with alkaline phosphatase-conjugated goat 
anti-rabbit IgG. The blots were washed with 
TBS-Tween and developed with nitro blue tetra- 
zolium and 5-bromo-4-chloro-3-indolyl phosphate 
as the chromogenic substrate. 
Resu l ts  
Fifty articular cartilage specimens from 28 
patients operated for joint replacement arthro- 
plasty (19-84 years old, x = 58.3) were examined for 
the presence of IL-I~t and IL-I~. Histological 
grades for these specimens ranged from 1 10. 
Immunochemical examination revealed the pres- 
ence of chondrocyte-associated IL-lct and IL-I[~ in 
many specimens of OA cartilage. The series of 
photomicrographs in Fig. 1 shows the immuno- 
chemical staining of a typical specimen of 
mildly-osteoarthritic cartilage (grade 4). Cells 
reactive with both anti-IL-l~ and IL-I~ antibody 
were evident in the superficial region but also 
distributed throughout he deeper layers of the 
articular cartilage. Chondrocyte staining for IL-I~ 
was generally more intense than for IL-I~, and 
more of the specimens were positive for this form 
of the cytokine. In some chondrocytes, IL-I~ 
appeared to be nuclear in localization. A diffuse 
staining of the extracellular matrix, strongest in 
the superficial region, was observed in sections 
from most OA specimens stained with the antibody 
to IL-I~ but not with the IL-I~ antibody. The 
positive staining reactions were abolished if the 
primary antibodies were replaced by non-immune 
rabbit IgG at the same concentration or with 
rabbit anti-IL-1 IgG preincubated with human 
recombinant IL-1. 
IL-I~ and IL-1 ~ immunochemical staining varied 
with OA severity as measured by histological 
evaluation. Mild to moderate OA cartilage had a 
higher percentage of IL-I~- and IL-l~-positive cells 
than more severely-degenerated cartilage (Fig. 2). 
Regression analysis revealed a strong inverse 
correlation (R2=0.825) of IL-lct immunochemical 
score and histological grade. A moderate inverse 
correlation (R 2=0.557) of IL-I~ immunochemical 
score with histological grade was also noted, with 
severely degenerated specimens (>grade 7) ex- 
hibiting very little IL-I~ immunostaining. 
OA specimens were divided into two cohorts 
based on histological grade for statistical analysis 
(Table I). In severe OA specimens (grade 7-10), the 
frequency of IL-l-positive cells was significantly 
reduced compared with the mild to moderate OA 
specimens, grades 1-6 (P < 0.00001 for IL-I~, 
P < 0.02 for IL-I~). 
Specimens obtained from five individuals not 
diagnosed as having joint disease (20-75 year old, 
mean 55.8 years) showed histologic evidence of at 
least early degenerative changes--surface irregu- 
larities and slight loss of safranin-O staining-- 
with mean score of 2.4 for OA severity. These 
cartilages ('asymptomatic' in Table I) produced 
lower mean scores for both IL-ls than specimens 
from OA patients showing early degenerative 
changes (grades 1-6), but the difference was 
significant only for IL-lu (P < 0.02). 
In order to determine whether the IL-ls 
associated with OA chondrocytes are in the 
precursor or processed form, IL-1 polypeptides in 
chondrocytes isolated from four OA cartilage 
specimens (grade 4) were analyzed by Western 
blotting of cell lysate proteins. Western blots of 
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Table I 
IL-I~ and fi immunostaining in OA cartilage 
Group* N H/HCt IL-I~$ IL-1135 
Asymptomatic 5 2.4 +_ 1.8 1.6 + 0.6 1.2 + 1.6 
Mild-moderate OA 37 3.5 + 1.3 2.6+1.1 1.9+1.5 
Severe OA 13 8.1+1.2 0.9+_0.6 0.8_+1.2 
*OA specimens that were mildly osteoarthritic based on 
histological criteria (grade 1 6) were compared with severe 
specimens (grade 7-10). The group identified as 'asymptomatic' 
consists of specimens from patients without a clinical history 
of joint disease (histological grade 1-4). 
tTissue sections stained with safranin-O and hematoxylin 
and eosin were scored for OA severity using the histological 
histochemical grading system of Mankin [29]. Values are the 
mean score ± standard eviation for N specimens in each group. 
:~Sections were stained using anti-human rIL-la or IL-I~ or 
normal rabbit IgG. Immunochemical scores were assigned for 
each specimen as described under Methods based on the 
percentage of positive chondrocytes: no immunoreactive cells 
as 0. less than 26% as 1.26-50% as 2, 51 75% as 3, and greater 
than 75% positive as 4. Values are the mean score ± standard 
deviation for N specimens in each group. Immunochemical 
score comparison: mild to moderate versus severe OA, IL-la, 
P< 0.00001 IL-I~, P < 0.02. Asymptomatic versus mild to 
moderate OA (IL-la P < 0.02). 
chondrocyte lysates stained for IL-lc( yielded an 
intense immunoreact ive band at ~ 33 kDa consist- 
ent with nascent IL-lu (Fig. 3, left arrow). IL-113 
was detected as an immunoreact ive band at 
18 kDa, the size of the processed form, in only one 
of the four OA chondrocyte lysates (right arrow). 
The anti- IL- l~ ant iserum nonspecif ical ly stained 
a ~50 kDa protein i  the chondrocyte lysates. 
Reactivity with the 33 kDa protein was abolished 
by preincubat ion of the IgG fraction with human 
recombinant  IL-I~, but staining of the 50kDa 
chondrocyte protein was unaffected. Thus, the 
50 kDa signal was nonspecific. 
Discussion 
In this study, IL-I~ and IL-I~ cytokines have 
been detected in the chondrocytes of mildly- 
osteoarthr it ic  human carti lage. We have pre- 
viously demonstrated IL-1 mRNAs in human 
chondrocytes, but the possibil ity exists that these 
genes were induced during the cell isolation 
procedures. The detection of IL- ls by immunohisto- 
chemistry in histological sections of surgical 
specimens proves that  IL-1 is present in vivo in OA 
carti lage. A demonstrat ion of IL-1 transcr ipts in 
OA chondrocytes by in-situ hybridization on a 
similar group of specimens would provide useful 
confirmation for our findings. 
IL- l-posit ive chondrocytes were distr ibuted 
through all layers of the cart i lage in mildly- 
osteoarthr it ic  specimens. Regional var iat ion in the 
number of IL-1 positive chondrocytes, as well as in 
the intensity of staining, was noted in some 
specimens, but there was no consistent pattern of 
IL-1 staining in areas of 'cloning', fibrillation, or 
proteoglycan depletion. In a related study using a 
canine OA model, IL-1 positive chondrocytes were 
found primari ly in the superficial and middle 
layers and in heavi ly fibril lated areas, with 
matr ical  staining in the superficial region and 
along fissures [26]. In the study of human OA 
cart i lage specimens reported here, IL-I~ immuno- 
staining of the extracel lular matr ix was usually 
1 2 3 4 5 6 7 8 
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FIG. 3. Immunoblot analysis of IL-1 in lysates of chondrocytes i olated from OA cartilage specimens. Proteins were 
extracted from chondrocytes i olated by digestion with clostridial collagenase from articular cartilage of four OA 
patients (grade 4). Extracts (40 pg/lane) were resolved by SDS-PAGE, and the protein was transferred to Immobilon 
for immunochemical staining using antiserum to IL-I~ (lanes 1-4) or IL-I~ (lanes 5-8). Left arrow, proteins pecifically 
reactive with the IL-I~ antibody at 33 kDa corresponding to the precursor form of IL -h  in all four lysates tested. Right 
arrow, the processed 18 kDa IL-I~ species is detectable in only one of four lysates. The prominant ~ 50 kDa band stained 
with IL-I~ antiserum represents nonspecific reactivity unrelated to IL-I~ (see text). 
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limited to the superficial region, although oc- 
casional specimens exhibited a more disperse 
staining. (No staining of extracellular matrix was 
seen using the antibody to IL-I~.) Matrical IL-I~ 
immunoreactivity could represent chondrocyte- 
derived IL-1, but the principal source is probably 
the synovial fluid. II-ls that traverse the cartilage 
extracellular matrix and bind to IL-1 receptors 
would be internalized, possibly contributing to the 
chondrocyte immunoreactivity for IL-I~. 
We have only limited data on IL-ls in healthy 
human cartilage. Specimens were obtained from 
several individuals without a clinical history of 
joint disease. However, most specimens howed 
evidence of at least early degenerative changes-- 
surface irregularities and reduction in safranin O 
staining with scores ranging from 1-4 in OA 
severity. Previous epidemiological studies have 
reported on the prevalence of osteoarthritic 
changes in people over 35 years of age [29]. Thus, 
it is difficult to obtain specimens of adult cartilage 
that are truly normal. Basal IL-1 synthesis in 
chondrocyte cultures (rabbit and human) is 
reportedly low or undetectable [30, 31]. Further- 
more, few IL-1 immunopositive chondrocytes were 
detected in control canine cartilage [26] or normal 
human cartilage [27]. Taken together, these data 
indicate that IL-1 genes are probably only 
minimally expressed in healthy adult cartilage. 
Somewhat surprising was the progressive de- 
crease in the percentage of IL-l~-positive chondro- 
cytes with increased OA severity. Mildly- 
osteoarthritic artilage specimens graded 3-4 
based on histological evidence of degenerative 
changes exhibited intense IL-I~ and IL-I~ staining 
in and around chondrocytes. Interestingly, examin- 
ation of OA cartilage by several criteria cellular- 
ity, metabolic activity, and synthesis of matrix 
metalloprotease-3 (MMP-3)-resolves OA pro- 
gression into two distinct phases [28, 32]. The 
breakpoint separating the two disease phases, 
however, varies depending on the criterion 
considered. Mankin et al. [28] reported a positive 
correlation of biosynthetic activity ([:~S]O4 and 
[3H] thymidine incorporation) with OA severity up 
to grade 10. The reason for the dramatic decrease 
in metabolic activity late in the disease, the 
so-called 'point of no return', is not clear, but may 
be attributable at least in part to cell death. Thus, 
the decline of IL-1 with OA progression reported 
here and of MMP-3 as reported by Okada et al. [32] 
precede the crisis point and are probably not due 
solely to cell death. 
Information on the sizes of IL-1 polypeptides 
present in OA chondrocytes is important in order 
to understand the potential of these cytokines to 
mediate autocrine or paracrine signaling within 
the cartilage. In monocytes, the primary trans- 
lation products of both IL-1 genes are proteolyti- 
cally processed to biologically active 18 kDa forms 
found in extracellular fluids [1, 2]. Other celt types 
such as keratinocytes have predominantly the 
precursor forms of IL-1, virtually none being 
processed to the 18 kDa form [33]. Exogenous IL-I~ 
precursor, in contrast to unprocessed IL-I~, is 
capable of interacting with cell surface receptors 
to produce a biological response [34]. In addition, 
the IL-I~ precursor has a nuclear localization 
signal, and may exert direct autocrine effects 
independent of cell surface receptors, as has been 
reported for transformed endothelial cells [35]. 
Immunoblot analysis demonstrated that chon- 
drocyte-associated IL-lu in mildly-osteoarthritic 
cartilage is almost exclusively the 33 kDa precur- 
sor. Because only the precursor form of IL-lu was 
identified in lysates of chondrocytes isolated from 
OA cartilage, origin of this cytokine from another 
source such as synovium is unlikely. This finding 
supports the contention that the chondrocytes 
synthesize this cytokine. IL-I~, detected in only 
one of four chondrocyte lysates, appeared predom- 
inantly as the processed 18kDa species. This 
observation suggests the possibility that at least a 
portion of the IL-I~ immunoreactivity in OA 
cartilages may represent cytokine from exogenous 
sources internalized through receptor mediated 
endocytosis. 
While IL-1 is associated with the chondrocytes of 
cartilage showing early degenerative changes, the 
effects of the cytokines on the cells in vivo are 
unknown. IL-ls may be sequestered intracellularly, 
interacting with receptors only after release from 
dying cells; or, chondrocytes might process and 
release IL-I~, and perhaps IL-I~ to recruit 
surrounding cells into a degenerative pathway. A 
third possibility is that, as in transformed 
endothelial cells [35], precursor IL-I~ exerts true 
autocrine effects on transcription of genes 
encoding proteins such as collagenase after its 
translocation to the nucleus. The apparent 
nuclear localization of IL-I~ immunoreactivity in 
some OA chondrocytes is being investigated in this 
regard. 
IL-1 stimulates MMP-3 gene expression in 
cartilage [16, 20]. This metalloproteinase poten- 
tially contributes to the destruction of the 
extracellular matrix by degrading cartilage macro- 
molecules. The capacity of IL-1 to induce MMP-3 
synthesis and stimulate cartilage degradation 
together with its presence in cartilage in the early 
stages of osteoarthritic disease suggests a role for 
these cytokines in OA pathogenesis. 
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